Natera co-founder sells $2.8 million in stock, with positive revenue growth and strong market position.

From Investing.com: 2024-09-20 21:36:50

Sheena Jonathan, Co-Founder of Natera, Inc. (NASDAQ:), sold over $2.8 million worth of company stock in multiple transactions on September 18, 2024. The sale involved various blocks of shares sold at prices ranging from $127.3779 to $128.0748, conducted through Rule 10b5-1 plans adopted on different dates.

Natera, Inc. reported a 12% sequential revenue increase and a 58% year-over-year surge, leading to an upward revision in full-year revenue guidance to approximately $1.5 billion. Analysts from Piper Sandler, TD Cowen, and Canaccord Genuity maintained positive ratings, emphasizing Natera’s strong market position and growth potential, particularly with its cancer test, Signatera.

Investors are closely monitoring Natera’s financial health and stock performance following insider transactions by Sheena Jonathan. Despite not being profitable in the last twelve months, Natera has shown impressive revenue growth, with a 46.13% increase in the past year as of Q2 2024, and a 58.13% quarterly revenue growth in Q2 2024. The stock has also experienced strong returns in the market.



Read more at Investing.com: Natera co-founder sells over $2.8 million in company stock By Investing.com